21147 ⎘
Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma Purification
PHOSPHORYLATED ANTIGEN AND ANTIBODY AT SER23 SITE OF PGAM1 PROTEIN AS WELL AS PREPARATION METHODS AND APPLICATIONS
#2METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF
#3MODIFIED TNF AS A CAPTURE LIGAND
#4Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins
#5Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
#6REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE
#7Modified TNF as a capture ligand
#8Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
#9METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION WITH IMPROVED YIELD
#10Removal of serine proteases by treatment with finely divided silicon dioxide
#11ANTI-EGFR ANTIBODY DRUG CONJUGATE FORMULATIONS
#12IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF
#13Removal of serine proteases by treatment with finely divided silicon dioxide
#14IMMUNOTHERAPEUTIC USES OF EX VIVO GENERATED FOXP3+ REGULATORY T CELLS
#15Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
#16Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
#17Cyclic peptide, affinity chromatography support, labeled antibody, antibody drug conjugate, and pharmaceutical preparation
#18Methods for preparing hepatitis B immunoglobulin derived from plasma
#19Fluorescent conjugates
#20Removal of serine proteases by treatment with finely divided silicon dioxide
#21Fluorescent conjugates
#22Removal of serine proteases by treatment with finely divided silicon dioxide
#23Affinity chromatography matrix
#24Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography
#25Removal of serine proteases by treatment with finely divided silicon dioxide
#26Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs
#27Process for obtaining an IgG composition through heat treatment
#28Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
#29Removal of serine proteases by treatment with finely divided silicon dioxide
#30Removal of serine proteases by treatment with finely divided silicon dioxide
#31Protein purification using HCIC and ion exchange chromatography
#32Removal of serine proteases by treatment with finely divided silicon dioxide
#33Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography
#34Protein purification using HCIC and ion exchange chromatography
#35Methods of depleting antibodies directed towards major histocompatibility complex
#36Methods for refolding of recombinant antibodies